Research Compliance has identified a list of biological agents approved for use within the Boston University\/Boston Medical Center research community that have the potential to cause laboratory acquired infection (LAI)<\/a>. While LAI is a rare event, the research community continues to take proactive measures to further mitigate risk to researchers, safety personnel and medical providers.<\/p>\n The list of biological agents with the potential to cause LAI is dynamic and will be routinely reviewed for pathogens that researchers are proposing to use. As new agents approved by the IBC are introduced into the laboratory environment, they may be added to the list or as agents are no longer being used they will be removed from the list. Contact the IBC Office at ibc@bu.edu<\/a> for the current list.<\/p>\n Principal Investigators, researchers and any other personnel listed on approved Institutional Biosafety Committee (IBC) protocols involving these biological agents with the potential to cause LAI must receive agent specific training.<\/p>\n ROHP will support the efforts of Research Compliance and IBC to mitigate the potential and effect of LAI as follows:<\/p>\n These cards have been issued to all personnel currently working with any of the biological agents included on the IBC list and, in the future, these cards will be issued to any personnel added to existing or included in new research protocols using these agents after IBC approval has been granted.<\/p>\n The card is provided to facilitate prompt medical attention and appropriate medical care in the event the card holder should experience symptoms or illness while away from BU\/BMC that may be related to activities or exposures.<\/p>\n When seeking treatment for these symptoms or illness (primary care physician, local hospital, ED, etc\u2026), present this card to the attending physician or medical provider so that they can contact ROHP by phone or visit our website to get more information about the hazards, symptoms and treatment for these biological agents. Physicians can utilize this information to formulate the appropriate diagnosis as many diseases can have flu-like symptoms.<\/li>\n ROHP has worked together with the Office of Research Safety to prepare individual information sheets focused on laboratory safety. The sheets contain agent specific information on safety and handling precautions, recognition of transmission and symptoms, medical contact information and immediate first aid in the event of an exposure.<\/p>\n These sheets are available online and will be reviewed with and issued to each PI and researcher by ROHP as part of the medical clearance process prior to IBC protocol approval. For additional information and resources on emerging infectious diseases please refer to The Association of Biosafety and Biosecurity (ABSA International)<\/a>.<\/span><\/li>\n ROHP is working together with Principal Investigators to prepare agent specific information sheets that provide instructions for medical and research personnel to follow in the event of a possible exposure to a Laboratory Acquired Infection (LAI).\u00a0 We have emergency response algorithms to follow and participate in medical response drills to prepare in the event of an incident.<\/p>\n The agent specific information sheets contain medical and safety information that encompasses transmission, symptoms, safety precautions, immediate first aid, emergency medical contact information, diagnosis and laboratory testing, vaccinations, and post-exposure prophylaxis and treatment.<\/p>\n Researchers are assigned specific agent training by their Supervisor, Principal Investigator, and\/or Biosafety Officer. ROHP offers researchers and research support staff pre-exposure prophylaxis.<\/li>\n<\/ul>\n Biological Agents Research Compliance has identified a list of biological agents approved for use within the Boston University\/Boston Medical Center research community that have the potential to cause laboratory acquired infection (LAI). While LAI is a rare event, the research community continues to take proactive measures to further mitigate risk to researchers, safety personnel and […]<\/p>\n","protected":false},"author":4042,"featured_media":0,"parent":3108,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/pages\/5281"}],"collection":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/users\/4042"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/comments?post=5281"}],"version-history":[{"count":50,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/pages\/5281\/revisions"}],"predecessor-version":[{"id":60566,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/pages\/5281\/revisions\/60566"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/pages\/3108"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/media?parent=5281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
Issue Medical Surveillance Wallet Cards<\/h4>\n
Prepare Agent Information Sheets<\/h4>\n
Laboratory Acquired Infection Exposure Prevention<\/h4>\n
Links to all agent information sheets<\/h3>\n
BSL-4 Agents<\/h4>\n
\n
BSL-3 Agents<\/h4>\n
\n
BSL-2+\/BSL-3 Agent<\/h4>\n
\n
BSL-2 Agents<\/h4>\n
\n